A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
Status:
Recruiting
Trial end date:
2022-09-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics,
pharmacodynamics, and early clinical activity of single-agent INCB081776 (Part 1) and
INCB081776 in combination with INCMGA00012 (Part 2).